BR112014010782A2 - composições farmacêuticas de moduladores de receptor de androgênio seletivos e aplicações das mesmas - Google Patents

composições farmacêuticas de moduladores de receptor de androgênio seletivos e aplicações das mesmas

Info

Publication number
BR112014010782A2
BR112014010782A2 BR112014010782A BR112014010782A BR112014010782A2 BR 112014010782 A2 BR112014010782 A2 BR 112014010782A2 BR 112014010782 A BR112014010782 A BR 112014010782A BR 112014010782 A BR112014010782 A BR 112014010782A BR 112014010782 A2 BR112014010782 A2 BR 112014010782A2
Authority
BR
Brazil
Prior art keywords
applications
pharmaceutical compositions
androgen receptor
receptor modulators
selective androgen
Prior art date
Application number
BR112014010782A
Other languages
English (en)
Inventor
T Dalton James
Gosnell Matthew
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtx Inc filed Critical Gtx Inc
Publication of BR112014010782A2 publication Critical patent/BR112014010782A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112014010782A 2011-11-03 2012-11-01 composições farmacêuticas de moduladores de receptor de androgênio seletivos e aplicações das mesmas BR112014010782A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161555179P 2011-11-03 2011-11-03
PCT/US2012/063048 WO2013067170A1 (en) 2011-11-03 2012-11-01 Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112014010782A2 true BR112014010782A2 (pt) 2017-06-13

Family

ID=48192762

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014010782A BR112014010782A2 (pt) 2011-11-03 2012-11-01 composições farmacêuticas de moduladores de receptor de androgênio seletivos e aplicações das mesmas

Country Status (6)

Country Link
US (1) US20130122085A1 (pt)
AU (1) AU2012324013A1 (pt)
BR (1) BR112014010782A2 (pt)
CA (1) CA2853965A1 (pt)
IL (1) IL232351A0 (pt)
WO (1) WO2013067170A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007045027A1 (en) 2005-10-19 2007-04-26 Chavah Pty Ltd Reduction of side effects from aromatase inhibitors used for treating breast cancer
US20150246060A1 (en) 2013-03-15 2015-09-03 Iceutica Inc. Abiraterone Acetate Formulation and Methods of Use
AU2014235854B2 (en) 2013-03-21 2019-04-11 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
US20150157646A1 (en) * 2013-09-27 2015-06-11 Iceutica Inc. Abiraterone Steroid Formulation
CN107106506A (zh) * 2014-09-19 2017-08-29 优普顺药物公司 用于治疗剂的超局部化释放的可注射微粒
CA2965372C (en) 2014-10-22 2023-09-05 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
CN106551804B (zh) * 2015-09-30 2022-04-26 董玲 一种使用滚模制备冻干赋形制剂的方法及其产品
CA3002562A1 (en) 2015-10-22 2017-04-27 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
ES2672993T3 (es) 2015-10-27 2018-06-19 Eupraxia Pharmaceuticals Inc. Formulaciones de liberación sostenida de anestésicos locales
US11208247B2 (en) * 2017-07-31 2021-12-28 Société des Produits Nestlé S.A. Packaging for solid dosage forms of melatonin with a high citric acid concentration
EP3976048A4 (en) 2019-06-03 2023-07-12 Havah Therapeutics Pty Ltd PHARMACEUTICAL FORMULATIONS AND SYSTEMS FOR THE ADMINISTRATION OF AN ANDROGEN AGENT AND AN AROMATASE INHIBITOR, AND METHODS OF USE
AU2020296816A1 (en) * 2019-06-18 2022-02-10 Strongbridge Dublin Limited Dichlorphenamide compositions and methods of use
KR20240037990A (ko) * 2021-07-06 2024-03-22 알.피.쉐러 테크놀러지즈 엘엘씨 소프트겔 캡슐
AR128560A1 (es) * 2022-02-18 2024-05-22 Scherer Technologies Llc R P Cápsula blanda de ácido valproico de liberación modificada
US20240307410A1 (en) * 2022-12-05 2024-09-19 Edward Dunne Corboy, JR. 5 alpha dihydrotestosterone formulations and associated methods of use and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
CA2709677C (en) * 2007-12-21 2017-03-14 Lin Zhi Selective androgen receptor modulators (sarms) and uses thereof

Also Published As

Publication number Publication date
US20130122085A1 (en) 2013-05-16
AU2012324013A1 (en) 2013-05-23
WO2013067170A1 (en) 2013-05-10
CA2853965A1 (en) 2013-05-10
IL232351A0 (en) 2014-06-30

Similar Documents

Publication Publication Date Title
BR112014010782A2 (pt) composições farmacêuticas de moduladores de receptor de androgênio seletivos e aplicações das mesmas
CY2021032I2 (el) Κρυσταλλiκες μορφες διαμορφωτη υποδοχεα ανδρογονων
BR112014020543A2 (pt) composições de ração e métodos de utilização das mesmas
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
BR112013013025A2 (pt) composições i-i e produtos e usos desta
IL237272A (en) Pharmaceuticals that contain and use androgen receptor modulators
BR112015003354A8 (pt) métodos e composições de microcápsula
DK3527241T3 (da) Indretning til administration af lægemiddel
BR112013002845A2 (pt) combinação de susbtâncias ativas
BR112014007124A2 (pt) superfamília de peptídeos gluxagon que exibem atividade no receptor glicocorticóide
SMT201600410B (it) Modulatori diidropirazolici di gpr40
BR112014003052A2 (pt) composições farmacêuticas
DK3246018T3 (da) Farmaceutisk sammensætning
SMT201700009B (it) Modulatori del recettore x del fegato
BR112013014644A2 (pt) composição farmacêutica e complexo
CO6930367A2 (es) Composiciones farmaceúticas
BR112014006291A2 (pt) composição e utilização da composição
SMT201600374B (it) Modulatori del recettore x del fegato
EE201300005A (et) Ravimkoostis
DK2897594T3 (da) Farmaceutisk sammensætning
DK2815752T3 (da) Oral farmaceutisk sammensætning
CO6910195A2 (es) Moduladores selectivos del receptor andrógeno
BR112014026397A2 (pt) composição e uso de uma composição
BR112015002646A2 (pt) composto e composição farmacêutica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]